Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity
Your health care provider at Valhalla Vitality will be able to provide more information about cost, dosage, side effects and other important details regarding semaglutide injections
Dosage: 3 grams per day
A standard 5-ounce pour contains about 125 calories of what nutrition experts sometimes call empty calories, those without the protein, fiber, or healthy fats that help keep you satisfied
In April 2025, the company discontinued its main obesity candidate, danuglipron, due to safety concerns
Tirzepatide is a newer medication and is still being assessed for its long-term effects and potential additional benefits, such as cardiovascular outcomes
US$ 29.18
US$ 25.71
US$ 27.56
